OS Command Injection vulnerability affecting BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023
CVE-2023-6078

8.8HIGH

Key Information:

Vendor

Dassault Systèmes

Status
Biovia Materials Studio Products
Vendor
CVE Published:
1 February 2024

What is CVE-2023-6078?

An OS Command Injection vulnerability exists in BIOVIA Materials Studio products from Dassault Systèmes, spanning Releases 2021 to 2023. This vulnerability allows attackers to upload a specially crafted perl script, potentially leading to arbitrary execution of system commands. Organizations using affected versions should evaluate their security posture and apply necessary mitigations to prevent exploitation.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

BIOVIA Materials Studio products BIOVIA 2021 Golden

BIOVIA Materials Studio products BIOVIA 2022 Golden

BIOVIA Materials Studio products BIOVIA 2023 Golden

References

https://www.3ds.com/vulnerability/advisories

CVSS V3.1

Score:
8.8
Severity:
HIGH
Confidentiality:
High
Integrity:
High
Availability:
High
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.